The influence of anti-endothelial/antiphospholipid antibodies on fibrin formation and lysis on endothelial cells

Angela Margaret Patterson, Isobel Ford, Audrey Graham, Nuala Booth, Michael Greaves

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The prothrombotic mechanisms associated with antiphospholipid antibodies remain incompletely defined. Antibody binding to endothelial cells in vitro is a feature of antiphospholipid antibody-positive sera. We hypothesised that impairment of endothelium-dependent fibrinolysis by antiphospholipid/anti-endothelial antibodies is a contributory factor in the pathogenesis of thrombosis. We also aimed to confirm the displacement of annexin-V from endothelial cells and enhanced fibrin formation. Binding of immunoglobulin (Ig) from antiphospholipid antibody-positive sera to endothelial cells was examined using a cell-based enzyme-linked immunosorbent assay. Effects on fibrin formation and lysis were examined on cultured endothelial cell monolayers. Plasminogen activator inhibitor-1 (PAI-1) was assayed in supernatants. We confirmed antibody binding to endothelial cells. With four of 14 antiphospholipid antibody-positive sera there was some prolongation of fibrin clot lysis time, consistent with impairment of endothelial fibrinolytic activity. Secretion of PAI-1 was significantly correlated with clot lysis time on endothelial cell monolayers incubated with antiphospholipid/anti-endothelial antibody-positive sera, but not with control sera. IgG from antiphospholipid antibody-positive sera had little effect on endothelial cell surface annexin-V expression. We conclude that impaired endothelial fibrinolysis is a potential prothrombotic mechanism in subjects with antiphospholipid antibodies. We were unable to confirm enhanced displacement of annexin-V from endothelium by antiphospholipid antibodies.

Original languageEnglish
Pages (from-to)323-330
Number of pages7
JournalBritish Journal of Haematology
Volume133
Issue number3
Early online date10 Feb 2006
DOIs
Publication statusPublished - May 2006

Keywords

  • anti-endothelial antibody
  • antiphospholipid antibody
  • fibrinolysis
  • primary antiphospholipid syndrome
  • systemic lupus-erythematosus
  • annexin-v
  • anticardiolipin antibodies
  • tissue factor
  • thrombogenic mechanism
  • protein-C
  • thrombosis
  • binding
  • membranes

Cite this

The influence of anti-endothelial/antiphospholipid antibodies on fibrin formation and lysis on endothelial cells. / Patterson, Angela Margaret; Ford, Isobel; Graham, Audrey; Booth, Nuala; Greaves, Michael.

In: British Journal of Haematology, Vol. 133, No. 3, 05.2006, p. 323-330.

Research output: Contribution to journalArticle

Patterson, Angela Margaret ; Ford, Isobel ; Graham, Audrey ; Booth, Nuala ; Greaves, Michael. / The influence of anti-endothelial/antiphospholipid antibodies on fibrin formation and lysis on endothelial cells. In: British Journal of Haematology. 2006 ; Vol. 133, No. 3. pp. 323-330.
@article{15378fd86e1043f3bca3841a2b145d42,
title = "The influence of anti-endothelial/antiphospholipid antibodies on fibrin formation and lysis on endothelial cells",
abstract = "The prothrombotic mechanisms associated with antiphospholipid antibodies remain incompletely defined. Antibody binding to endothelial cells in vitro is a feature of antiphospholipid antibody-positive sera. We hypothesised that impairment of endothelium-dependent fibrinolysis by antiphospholipid/anti-endothelial antibodies is a contributory factor in the pathogenesis of thrombosis. We also aimed to confirm the displacement of annexin-V from endothelial cells and enhanced fibrin formation. Binding of immunoglobulin (Ig) from antiphospholipid antibody-positive sera to endothelial cells was examined using a cell-based enzyme-linked immunosorbent assay. Effects on fibrin formation and lysis were examined on cultured endothelial cell monolayers. Plasminogen activator inhibitor-1 (PAI-1) was assayed in supernatants. We confirmed antibody binding to endothelial cells. With four of 14 antiphospholipid antibody-positive sera there was some prolongation of fibrin clot lysis time, consistent with impairment of endothelial fibrinolytic activity. Secretion of PAI-1 was significantly correlated with clot lysis time on endothelial cell monolayers incubated with antiphospholipid/anti-endothelial antibody-positive sera, but not with control sera. IgG from antiphospholipid antibody-positive sera had little effect on endothelial cell surface annexin-V expression. We conclude that impaired endothelial fibrinolysis is a potential prothrombotic mechanism in subjects with antiphospholipid antibodies. We were unable to confirm enhanced displacement of annexin-V from endothelium by antiphospholipid antibodies.",
keywords = "anti-endothelial antibody, antiphospholipid antibody, fibrinolysis, primary antiphospholipid syndrome, systemic lupus-erythematosus, annexin-v, anticardiolipin antibodies, tissue factor, thrombogenic mechanism, protein-C, thrombosis, binding, membranes",
author = "Patterson, {Angela Margaret} and Isobel Ford and Audrey Graham and Nuala Booth and Michael Greaves",
year = "2006",
month = "5",
doi = "10.1111/j.1365-2141.2006.05994.x",
language = "English",
volume = "133",
pages = "323--330",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - The influence of anti-endothelial/antiphospholipid antibodies on fibrin formation and lysis on endothelial cells

AU - Patterson, Angela Margaret

AU - Ford, Isobel

AU - Graham, Audrey

AU - Booth, Nuala

AU - Greaves, Michael

PY - 2006/5

Y1 - 2006/5

N2 - The prothrombotic mechanisms associated with antiphospholipid antibodies remain incompletely defined. Antibody binding to endothelial cells in vitro is a feature of antiphospholipid antibody-positive sera. We hypothesised that impairment of endothelium-dependent fibrinolysis by antiphospholipid/anti-endothelial antibodies is a contributory factor in the pathogenesis of thrombosis. We also aimed to confirm the displacement of annexin-V from endothelial cells and enhanced fibrin formation. Binding of immunoglobulin (Ig) from antiphospholipid antibody-positive sera to endothelial cells was examined using a cell-based enzyme-linked immunosorbent assay. Effects on fibrin formation and lysis were examined on cultured endothelial cell monolayers. Plasminogen activator inhibitor-1 (PAI-1) was assayed in supernatants. We confirmed antibody binding to endothelial cells. With four of 14 antiphospholipid antibody-positive sera there was some prolongation of fibrin clot lysis time, consistent with impairment of endothelial fibrinolytic activity. Secretion of PAI-1 was significantly correlated with clot lysis time on endothelial cell monolayers incubated with antiphospholipid/anti-endothelial antibody-positive sera, but not with control sera. IgG from antiphospholipid antibody-positive sera had little effect on endothelial cell surface annexin-V expression. We conclude that impaired endothelial fibrinolysis is a potential prothrombotic mechanism in subjects with antiphospholipid antibodies. We were unable to confirm enhanced displacement of annexin-V from endothelium by antiphospholipid antibodies.

AB - The prothrombotic mechanisms associated with antiphospholipid antibodies remain incompletely defined. Antibody binding to endothelial cells in vitro is a feature of antiphospholipid antibody-positive sera. We hypothesised that impairment of endothelium-dependent fibrinolysis by antiphospholipid/anti-endothelial antibodies is a contributory factor in the pathogenesis of thrombosis. We also aimed to confirm the displacement of annexin-V from endothelial cells and enhanced fibrin formation. Binding of immunoglobulin (Ig) from antiphospholipid antibody-positive sera to endothelial cells was examined using a cell-based enzyme-linked immunosorbent assay. Effects on fibrin formation and lysis were examined on cultured endothelial cell monolayers. Plasminogen activator inhibitor-1 (PAI-1) was assayed in supernatants. We confirmed antibody binding to endothelial cells. With four of 14 antiphospholipid antibody-positive sera there was some prolongation of fibrin clot lysis time, consistent with impairment of endothelial fibrinolytic activity. Secretion of PAI-1 was significantly correlated with clot lysis time on endothelial cell monolayers incubated with antiphospholipid/anti-endothelial antibody-positive sera, but not with control sera. IgG from antiphospholipid antibody-positive sera had little effect on endothelial cell surface annexin-V expression. We conclude that impaired endothelial fibrinolysis is a potential prothrombotic mechanism in subjects with antiphospholipid antibodies. We were unable to confirm enhanced displacement of annexin-V from endothelium by antiphospholipid antibodies.

KW - anti-endothelial antibody

KW - antiphospholipid antibody

KW - fibrinolysis

KW - primary antiphospholipid syndrome

KW - systemic lupus-erythematosus

KW - annexin-v

KW - anticardiolipin antibodies

KW - tissue factor

KW - thrombogenic mechanism

KW - protein-C

KW - thrombosis

KW - binding

KW - membranes

U2 - 10.1111/j.1365-2141.2006.05994.x

DO - 10.1111/j.1365-2141.2006.05994.x

M3 - Article

VL - 133

SP - 323

EP - 330

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 3

ER -